Skip to main content

Data and Information

By HIMSS TV | 03:22 pm | September 06, 2024
At the HIMSS AI in Healthcare Forum in Boston, CEO of HIMSS Hal Wolf highlights the challenges health systems face globally integrating AI, leveraging the technology to ensure beneficial healthcare delivery and regulations pertaining to AI.
By Anthony Vecchione | 02:43 pm | September 06, 2024
The collaboration will leverage Genetic Leap's RNA-targeted AI platform to create genetic medicines against selected targets.  
By HIMSS TV | 12:00 pm | September 06, 2024
David Heaney, CISO at Mass General Brigham, relays best practices for securing AI use in health systems to ensure proper adoption, implementation and cybersecurity - and the types of AI that security specialists use to ward off cyberattacks.
By HIMSS TV | 12:00 pm | September 05, 2024
Organizations need to ask how they can secure their use of AI technologies, use AI to secure the organization better and defend against AI-driven attacks, says Dave Heaney, chief information security officer at Mass General Brigham.
By Jessica Hagen | 02:04 pm | September 04, 2024
Affiliated Network Providers, Aurora Behavioral Health and Alera Health collaborate for behavioral healthcare in Arizona, and WorldView integrates Vivid Health's AI.
By HIMSS TV | 07:00 am | September 04, 2024
Dr Alexander Ryu, vice chair of Innovation and AI at Mayo Clinic, reveals best practices in planning and integrating AI into clinical practice.  
By HIMSS TV | 07:00 am | September 03, 2024
Robert Booker, chief strategy officer at HITRUST, discusses how the company is adjusting its risk and data management guidance for healthcare providers to ensure cybersecurity after the emergence of new threats posed by genAI in society.
By Anthony Vecchione | 03:29 pm | August 30, 2024
The project aims to promote AI-powered tech support for care providers and help streamline administrative tasks while boosting clinical decision-making.
By HIMSS TV | 07:00 am | August 30, 2024
QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.
By Jessica Hagen | 02:39 pm | August 29, 2024
Ben Robbins, general partner at GV, wraps up MobiHealthNews' investment series by unveiling the crucial traits digital health companies must possess to secure funding in a highly competitive market.